Suchergebnisse - "Göhler, Thomas"

PubPharm (47)

1

Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

enthalten in: British journal of cancer | 2024

von Schmoll, H. | Mann, J. | Meinert, F. | +20

2

Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy

enthalten in: Cancer treatment reviews | 2023

von Harbeck, N. | Kates, R. | Schinköthe, T. | +15

3

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer : Real-world data from the noninterventional TACTIC study in Germany

enthalten in: International journal of cancer | 2023

von Kröning, H. | Göhler, T. | Decker, T. | +23

4

Effectiveness, safety and quality of life of trifluridine/tipiracil in pretreated patients with metastatic colorectal cancer : Real‐world data from the noninterventional TACTIC study in Germany

enthalten in: International Journal of Cancer | 2023

von Kröning, H. | Göhler, T. | Decker, T. | +23

5

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer : Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Reinisch, M. | Untch, M. | Mahlberg, R. | +22

6

Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer : pharmacokinetic, safety and patients' preference : substudy of the randomised phase III GAIN-2 study

enthalten in: The breast | [December 2022]

von Reinisch, M. | Untch, M. | Mahlberg, R. | +22

7

A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer

enthalten in: Cancers | 2021

von Hecht, M. | Hahn, D. | Wolber, P. | +15

8

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

enthalten in: BMC cancer | 2020

von Hecht, M. | Hahn, D. | Wolber, P. | +15

9

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

enthalten in: BMC cancer | 2020

von Hecht, M. | Hahn, D. | Wolber, P. | +15

10

Treatment response lowers tumor symptom burden in recurrent and/or metastatic head and neck cancer

enthalten in: BMC cancer | 2020

von Hecht, M. | Hahn, D. | Wolber, P. | +15

1
2
3
4
5
Nächster »
[5]